Children admitted to hospital




Children who need to be admitted to hospital for any reason are exposed to hospital germs and the germs of other patients. These sick children face an increased risk of coming down with diarrhoea and respiratory tract infections throughout their stay in hospital.

Introducing  LACTOGG®’s probiotic strain during admission has been found to protect these children from hospital-acquired infections.

In a clinical trial, 742 children were given GG probiotic the moment they were admitted into hospital.

It was found that the "GG" children had over 3 times less chance of acquiring diarrhoea as well as throat and lung infections during their hospital stay, compared to the children who did not take GG probiotic.


Number of patients developing prolonged respiratory infections during hospital stay. [Hojsak et al. 2010]




References:

Hojsak I et al.Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010;125(5):e1171-1177

Szajewska H et al.Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001:138:361-5







Hong Kong PaediHealth (HK) Ltd. (1286528) 401 Jardine House, 1 Connaught Place, Central Hong Kong Tel: +852 3486 7233     Fax: +852 3486 3723 China Guangzhou Synthgensys Biotechnology Co. Ltd. Unit 501-1, No. 7, Spiral 4 Road, Guangzhou International Bioisland, P R China Tel: +0757 26616888     Fax: +0757 26382288
Singapore ProbioCare Pte. Ltd. (201603757R) 60 Paya Lebar Rd, #08-43 Paya Lebar Square, 409051 Singapore Tel: +65 6255 5592     Fax: +65 6255 5563 Malaysia ProbioCare Sdn. Bhd. (1124987-P) 122 Jalan Ipoh
51200 Kuala Lumpur
Malaysia Tel: +603 2011 1223     Fax: +603 2094 7723
FOLLOW US websiteusers@lactogg.com Brochures Privacy Policy Glossary
Copyright 2017-2018 Guangzhou Synthgensys Biotechnology Co.Ltd.